search
Back to results

A Prospective Blinded Randomized Study Comparing Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-y Gastric Bypass and Their Effect on Gastro-Esophageal Reflux Disease Using 24 Horus pH Monitoring (GERD)

Primary Purpose

GERD

Status
Suspended
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
24 pH monitoring
Esophageal Manometry:
Sponsored by
McMaster University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for GERD focused on measuring GERD, Laparoscopic, sleeve, gastrectomy

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Fulfilled criteria for bariatric surgery as coined by National Institutes of Health conference.
  • Their age is ≥18 years and ≤70 years
  • The group with symptoms of GERD needs to have diagnosis of GERD in their medical record and taking proton pump inhibitors on a daily basis.
  • Able and willing to give written consent
  • The patient is willing to perform the pre-operative tests required for this study.
  • The patient fits for both surgeries - LSG or LRYGB

Exclusion Criteria:

  • Previous bariatric surgery
  • Previous anti reflux procedure
  • Contra-indication to general anesthesia
  • Any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the investigational procedure
  • Pregnant or lactating female (Women of child bearing potential must take a pregnancy test prior to surgery)
  • Hiatal hernia above 4cm (measured in the pre-operative gastroscopy).
  • Multiple surgeries in abdominal cavity or previous small bowel disease/resection
  • Patient on CPAP treatment for his OSA disease

Sites / Locations

  • St. Joseph's Healthcare

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

GERD Symptoms

No GERD Symptoms

Arm Description

Outcomes

Primary Outcome Measures

Observe acid exposure to the distal esophagus
This will be measured using the esophageal 24 hours monitoring before surgery and at the 6 month follow up. The patients will be randomized to two different types of surgery and the results compared.

Secondary Outcome Measures

Compare GERD symptoms in patients.
This will be measured using esophageal manometry prior to surgery and at the six month follow up visit. We are looking for time in minutes with a pH of below 4 and a Demeeser score of below 14.7

Full Information

First Posted
March 24, 2014
Last Updated
April 25, 2017
Sponsor
McMaster University
search

1. Study Identification

Unique Protocol Identification Number
NCT02142998
Brief Title
A Prospective Blinded Randomized Study Comparing Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-y Gastric Bypass and Their Effect on Gastro-Esophageal Reflux Disease Using 24 Horus pH Monitoring
Acronym
GERD
Official Title
A Prospective Blinded Randomized Study Comparing Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-y Gastric Bypass and Their Effect on Gastro-Esophageal Reflux Disease Using 24 Horus pH Monitoring
Study Type
Interventional

2. Study Status

Record Verification Date
April 2017
Overall Recruitment Status
Suspended
Why Stopped
On hold due to poor enrollment and high drop-out rate.
Study Start Date
October 2014 (undefined)
Primary Completion Date
December 2018 (Anticipated)
Study Completion Date
December 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
McMaster University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Obesity has become a significant health problem in Canada. It is known to be a risk factor for many diseases, including Gastro-Esophageal Reflux Disease (GERD). When medical efforts to lose weight fail, patients often consider bariatric surgical procedures as the next step. The two most common bariatric procedures performed are Roux-en-Y Gastric Bypass (LRYGB) and Laparoscopic Sleeve Gastrectomy (LSG). The gold standard for diagnosing GERD is Esophageal pH monitoring, as it is the most objective method to document the reflux, assess the severity and monitor the response to treatment of the disease. In the last few years LSG has gained in popularity due to its simplicity and short operative time. Currently the comparison between bariatric surgery and GERD symptoms is very one sided. There are significant numbers of studies with conclusive results that state that LRYGB has a positive effect on GERD symptoms, however there is little evidence that states the same about LSG. This means that the relationship between LSG and GERD is inconclusive. An objective evaluation of GERD using 24 hour pH monitoring and validated CRFs at different follow up time points will contribute greatly to our understanding of what this relationship might be.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
GERD
Keywords
GERD, Laparoscopic, sleeve, gastrectomy

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
GERD Symptoms
Arm Type
Active Comparator
Arm Title
No GERD Symptoms
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
24 pH monitoring
Intervention Description
The study is performed with the patient fasting for a minimum of 6 hours. A single channel or dual channel (15 cm spacing) pH probe is inserted trans nasally. The pH sensor, or distal pH sensor in the case of 2 channel testing, is positioned 5 cm above the proximal margin of the LES, as determined by esophageal manometric testing. pH-Z ambulatory monitor (Given Imaging Digitrapper) is used for data acquisition and the data analyzed with pH Analysis Program (Given Imaging AccuView). The number of reflux events, defined as a drop in esophageal pH readings below 4.0, is recorded and the percentage of time with esophageal acid exposure is analyzed using defined protocols and accepted normal values.
Intervention Type
Other
Intervention Name(s)
Esophageal Manometry:
Intervention Description
A high resolution esophageal manometry catheter is used for testing and inserted Trans nasally. The patient is given 10 liquid swallows (5mL of water), at intervals of approximately 30 seconds. The catheter (Sierra Scientific/Given Imaging) has 36 sensors, each one averaging pressures from 12 circumferential positions. This gives a total of 432 data points. The sensors are placed 1 cm apart, spanning a length of 35 cm. The catheter simultaneously records pressure readings from the esophagus, sphincter regions (UES and LES), pharynx and stomach without the need for a station pull-through technique. Results are reported according to defined protocols and accepted normal values.
Primary Outcome Measure Information:
Title
Observe acid exposure to the distal esophagus
Description
This will be measured using the esophageal 24 hours monitoring before surgery and at the 6 month follow up. The patients will be randomized to two different types of surgery and the results compared.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Compare GERD symptoms in patients.
Description
This will be measured using esophageal manometry prior to surgery and at the six month follow up visit. We are looking for time in minutes with a pH of below 4 and a Demeeser score of below 14.7
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Fulfilled criteria for bariatric surgery as coined by National Institutes of Health conference. Their age is ≥18 years and ≤70 years The group with symptoms of GERD needs to have diagnosis of GERD in their medical record and taking proton pump inhibitors on a daily basis. Able and willing to give written consent The patient is willing to perform the pre-operative tests required for this study. The patient fits for both surgeries - LSG or LRYGB Exclusion Criteria: Previous bariatric surgery Previous anti reflux procedure Contra-indication to general anesthesia Any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the investigational procedure Pregnant or lactating female (Women of child bearing potential must take a pregnancy test prior to surgery) Hiatal hernia above 4cm (measured in the pre-operative gastroscopy). Multiple surgeries in abdominal cavity or previous small bowel disease/resection Patient on CPAP treatment for his OSA disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mehran Anvari, MB BS, PhD
Organizational Affiliation
Centre for Minimal Access Surgery, McMaster University
Official's Role
Principal Investigator
Facility Information:
Facility Name
St. Joseph's Healthcare
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N 4A6
Country
Canada

12. IPD Sharing Statement

Learn more about this trial

A Prospective Blinded Randomized Study Comparing Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-y Gastric Bypass and Their Effect on Gastro-Esophageal Reflux Disease Using 24 Horus pH Monitoring

We'll reach out to this number within 24 hrs